Correlation Between Protara Therapeutics and Galera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Galera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Galera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Galera Therapeutics, you can compare the effects of market volatilities on Protara Therapeutics and Galera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Galera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Galera Therapeutics.
Diversification Opportunities for Protara Therapeutics and Galera Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Protara and Galera is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Galera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galera Therapeutics and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Galera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galera Therapeutics has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Galera Therapeutics go up and down completely randomly.
Pair Corralation between Protara Therapeutics and Galera Therapeutics
Given the investment horizon of 90 days Protara Therapeutics is expected to generate 1.27 times more return on investment than Galera Therapeutics. However, Protara Therapeutics is 1.27 times more volatile than Galera Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Galera Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 314.00 in Protara Therapeutics on November 2, 2024 and sell it today you would earn a total of 136.00 from holding Protara Therapeutics or generate 43.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Protara Therapeutics vs. Galera Therapeutics
Performance |
| Timeline |
| Protara Therapeutics |
| Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protara Therapeutics and Galera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protara Therapeutics and Galera Therapeutics
The main advantage of trading using opposite Protara Therapeutics and Galera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Galera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galera Therapeutics will offset losses from the drop in Galera Therapeutics' long position.| Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology | Protara Therapeutics vs. Xilio Development |
| Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |